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ABSTRACT
Background: Mild traumatic brain injury (mTBI) is
a common injury among military personnel serving in
Iraq or Afghanistan. The impact of repeated episodes
of combat mTBI is unknown.
Objective: To evaluate relationships among mTBI,
post-traumatic stress disorder (PTSD) and
neurological deﬁcits (NDs) in US veterans who served
in Iraq or Afghanistan.
Methods: This was a caseecontrol study. From 2091
veterans screened for traumatic brain injury, the
authors studied 126 who sustained mTBI with one or
more episodes of loss of consciousness (LOC) in
combat. Comparison groups: 21 combat veterans who
had deﬁnite or possible episodes of mTBI without LOC
and 21 veterans who sustained mTBI with LOC as
civilians.
Results: Among combat veterans with mTBI, 52%
had NDs, 66% had PTSD and 50% had PTSD and an
ND. Impaired olfaction was the most common ND,
found in 65 veterans. The prevalence of an ND or PTSD
correlated with the number of mTBI exposures with
LOC. The prevalence of an ND or PTSD was >90% for
more than ﬁve episodes of LOC. Severity of PTSD
and impairment of olfaction increased with number of
LOC episodes. The prevalence of an ND for the 34
combat veterans with one episode of LOC
(4/34¼11.8%) was similar to that of the 21 veterans of
similar age and educational background who sustained
civilian mTBI with one episode of LOC (2/21¼9.5%,
p-NS).
Conclusions: Impaired olfaction was the most
frequently recognised ND. Repeated episodes of
combat mTBI were associated with increased
likelihood of PTSD and an ND. Combat setting may not
increase the likelihood of an ND. Two possible
connections between mTBI and PTSD are (1) that
circumstances leading to combat mTBI likely
involve severe psychological trauma and (2) that
altered cerebral functioning following mTBI may
increase the likelihood that a traumatic event results
in PTSD.
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ARTICLE SUMMARY
Article focus
- Caseecontrol study of mTBI associated with LOC
among US veterans who were deployed to Iraq or
Afghanistan during Operations Iraqi Freedom and
Enduring Freedom.
- Three study groups: (1) 126 veterans who had
mTBI with LOC, (2) 21 OIF/OEF veterans who did
not suffer mTBI with LOC and (3) 21 veterans
who sustained mTBI with LOC in a civilian
setting.
- Evaluated NDs including a quantitative test of
olfaction, PTSD with severity assessed using the
PCL-M instrument and a cognitive function using
the Montreal Cognitive Assessment Test.
Key messages
- Olfaction was a sensitive test for neurological
injury associated with mTBI with LOC.
- More episodes of mTBI with LOC were associated
with higher prevalence rates of NDs or of PTSD.
- The severity of PTSD and extent of olfactory
impairment increased with the number of
episodes of LOC; cognitive function performance
was inversely related to the number of episodes
of LOC.
Strengths and limitations of this study
- Caseecontrol study of US combat veterans with
mTBI who were assessed for NDs, PTSD and
cognitive function.
- Subjects and comparison groups had detailed
assessments for NDs, and combat veterans were
also assessed for PTSD.
- The ﬁndings should be relevant to other groups
of military personnel with combat mTBI.
- The neurological examination was not blinded.
- The selection of veterans in this study may be
biased because veterans who do not have health
issues may not seek care from the Department of
Veterans Affairs.
- The comparison groups were small.
- The ﬁndings in veterans with mTBI with LOC may
not apply to people with mTBI without LOC.
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Open Access ResearchINTRODUCTION
Traumatic brain injury (TBI) is a major worldwide cause
of death and disability. The worldwide incidence is about
10 million cases per year.
1 This is likely an underestimate
of the true incidence because cases of mild traumatic
brain injury (mTBI) are often unreported. In the USA,
TBI is the most common neurological diagnosis leading
to treatment in emergency/urgent care facilities with
about 1 million cases of TBI yearly and 50000 deaths per
year.
2 Most studies of TBI focus on moderate to severe
TBI, and there are relatively few studies of TBI incurred
in military combat. mTBI, or concussion, is a common
military injury among NATO troops serving in Iraq and
Afghanistan (OIF/OEF).
3 When US Army troops were
evaluated after a deployment to Iraq, between 15% and
20% reported at least one episode of TBI, predomi-
nantly mTBI.
4e6 In a study of US National Guard
soldiers who were deployed to Iraq, when queried
1 month before the end of a deployment, 9.2% of
soldiers reported an mTBI during the deployment and
22.0% reported an mTBI during the deployment when
queried 1 year later.
7 The cause for the delay in self-
recognition of mTBI is uncertain. Several factors may
increase reporting of mTBI after deployment. ‘Over
time, retrospective recall of combat events and history of
concussion/mTBI may be inﬂuenced by current symp-
toms of distress, attributions about current psychosocial
difﬁculties and secondary gain.’
7 Alternatively, mTBI
may be under-reported during a deployment. ‘While in
theater, soldiers may minimize reports of concussion/
mTBI history to remain with their units, live up to
perceived expectations of superiors and peers, and
ensure health concerns do not delay return home
during demobilization.’
7
Combat produces psychologically traumatic events;
hence, stress reactions including post-traumatic stress
disorder (PTSD) frequently accompany mTBI.
4 8 The
presence of some post-concussion symptoms such as
impaired memory appears to correlate more strongly
with the presence of PTSD rather than with mTBI.
47
However, post-traumatic headaches seem to be more
strongly associated with mTBI.
4 The prevalence of
neurological deﬁcits (NDs) associated with combat
mTBI and the relationships among ND, PTSD and
number of episodes of mTBI are unknown.
In this case-controlled observational study, we
screened 2091 OIF/OEF veterans and identiﬁed 126
veterans who had one or more episode of combat mTBI
associated with loss of consciousness (LOC). The
research questions we examined were (1) what are the
most frequently recognised NDs that can be identiﬁed
during an examination performed in a clinic setting? (2)
Do associations exist between the episodes of TBI
and NDs or PTSD? We evaluated veterans for NDs and
PTSD and correlated outcomes with LOC episodes. We
had two comparison groups. To evaluate whether
episodes of mTBI with LOC differed from mTBI without
LOC, we compared the ﬁndings in combat veterans who
experienced mTBI episodes with LOC to combat
veterans who did not have any LOC episodes. To
consider if a combat setting inﬂuenced the likelihood of
a veteran having residual NDs, we compared the ﬁndings
in combat veterans who experienced mTBI episodes with
LOC to veterans who suffered mTBI with LOC as civil-
ians. The veterans in the comparison groups had the
same testing as the veterans who had combat mTBI with
LOC, which led to the smaller sizes of the comparison
groups relative to the study group.
MATERIAL AND METHODS
This was a case-controlled observational study of a cohort
of OIF/OEF veterans with mTBI that began as
a Neurology Service Quality Assurance Monitor of the
evaluation of OIF/OEF veterans with mTBI. We
collected information from the veterans in an
unblinded, but uniform and prospective, manner.
Veterans did not sign consent forms. Data were collected
at the Louis Stokes Department of Veterans Affairs
Medical Center in Cleveland (CVAMC), which is
a regional Polytrauma Center that addresses the needs
of OIF/OEF veterans for most of the State of Ohio.
The CVAMC Institutional Review Board reviewed the
data in this report, approved waiver of HIPAA author-
isation, granted a waiver of informed consent and
approved submission of the data in this manuscript for
publication.
There were three study groups: (1) 126 OIF/OEF
veterans with one or more episode of LOC due to
combat mTBI, (2) 21 OIF/OEF veterans who had no
episodes of LOC and (3) 21 veterans who sustained an
episode of mTBI with LOC as civilians.
mTBI criteria
mTBI criteria was an episode of TBI with LOC <30 min,
duration of any alteration in consciousness (AOC)
following the TBI was <24 h and post-traumatic amnesia
(PTA) was <24 h.
9 We focused on veterans who had LOC
because TBI depended upon historical recall. In
a combat setting, it can be difﬁcult to distinguish AOC
from conﬂict-induced changes in arousal or emotion.
We deﬁned combat mTBI as occurring (1) during
engagement with enemy or (2) associated with an explo-
sion from an enemy device such as mortar/artillery shell,
rocket-propelled grenade, improvised explosive device or
bomb. Non-combat TBI occurred during a deployment
without enemy engagement or an explosion.
Subject selectiondOIF/OEF veterans
The OIF/OEF veterans were individuals who sought care
from the Veterans Health Administration of the United
States (VHA) often for issues not related to TBI such as
treatment of musculoskeletal pain or choosing VHA to
be their personal health resource. In addition, many
individuals had mental health issues such as depression
and PTSD. OIF/OEF veterans were screened for TBI
using a three-level sequential process. The ﬁrst screening
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istered to all OIF/OEF veterans treated by VHA.
10 For
those who conﬁrm OEF or OIF deployment and do not
have a prior diagnosis of TBI, the instrument proceeds
using four sequential question sets. The initial screen is
negative if a person responds negatively to any question
set. If the veteran afﬁrms one or more possible answer in
each section, the screen is positive. The four sections are
(1) events that could heighten the risk of TBI such as
explosion exposure; (2) immediate symptoms following
the event including LOC, AOC or PTA; (3) new or
worsening symptoms following the event and (4) current
symptoms that are consistent with TBI. The natural
history of mTBI is that most individuals with civilian
mTBI not associated with an explosion have resolution
of symptoms within 6 months.
11 The recovery pattern of
combat mTBI associated with an explosion is that
a greater fraction of individuals can have persisting post-
concussion symptoms following mTBI; however, these
individuals also have PTSD that is likely contributing to
the persistence of symptoms.
12 The symptoms in the
screen included alterations in cognition, behaviour,
motor or sensory function, balance or coordination
and the presence of pain including headache. During
a 24-month period between 2006 and 2008, 2091 OIF/
OEF veterans were screened with the four question TBI
screening tool
10 and 385 screened positive (18.4%). The
veterans who were screened were veterans who sought
healthcare with VHA. Figure 1 is a ﬂow chart indicating
the steps in identiﬁcation of study subjects. We have
a breakdown of the reasons that veterans screened
negative during a 6-month interval within the entire
24-month window that we considered. During that
6-month period, 2% of veterans who screened negative
indicated no exposure to an event associated with TBI
(ﬁrst screen section), 29% indicated that they did not
have symptoms following exposure to an event that
could produce TBI (second screen section), 31% indi-
cated that they did not develop new symptoms following
a TBI (third screen section) and 38% indicated that they
had symptoms following TBI but that they did not
currently have symptoms associated with TBI (fourth
screen section). Veterans identiﬁed on the ﬁrst screen
were encouraged to undergo a second-level evaluation
including an interview and physical examination; 350
had second-level screening (90.9%). The second-level
screening was consistent with TBI in 210 (60%) and 178
agreed to additional assessment (84.8%). Among the
178 veterans, 65 were initially interviewed by a nurse
practitioner (TP), trained in TBI assessment, to deter-
mine if they had sustained an episode of TBI; she found
that 42 (64.6%) had histories of mTBI with LOC. The
ﬁrst author (RLR) performed a detailed assessment of
the 113/178 veterans identiﬁed on the second-level
screen and not evaluated by the nurse practitioner plus
the 42 identiﬁed by the nurse practitioner, 155 veterans
in total. This assessment typically took 2.5 h. It consisted
of an interview, a structured neurological examination
and a cognitive assessment test (described below).
Veterans were asked, using open-ended questions, to
describe what happened when they may have had TBI.
Periods when the veteran was dazed or confused were
considered as possible episodes of AOC. Periods when
veterans could not remember what happened or had
gaps in their memories for events before or after
episodes of head trauma were considered to be PTA
episodes. For each episode, LOC referred to a period
when someone at the trauma scene observed the veteran
to be unresponsive or the veteran did not move when
prompted or nudged. If there were no observers,
veterans could indicate an episode of LOC by stating
that they clearly aroused or ‘woke-up’ following head
trauma.
The 155 veterans evaluated by RLR were divided into
two groups. One group contained 126 veterans who had
one or more episode of combat mTBI with LOC. The
second group contained 21 combat veterans who did not
sustain LOC: 11 veterans with mTBI in a combat setting,
ﬁve veterans who had mTBI in a non-combat setting and
ﬁve veterans who did not have a deﬁnite episode of TBI.
In the last su-group of ﬁve veterans, each veteran had at
least one episode of exposure to an explosion that was
associated with a behavioural change that RLR inter-
preted as possible but not deﬁnite episodes of AOC. The
episodes in these ﬁve veterans may have been changes in
arousal or emotion associated with combat rather than
episodes of AOC. Thus, in this group of 21 veterans, 16
had episodes of mTBI associated with AOC and ﬁve had
episodes that may have been mTBI. In comparisons, we
considered both the group of 16 veterans who had
deﬁnite episodes of mTBI without LOC and the larger
Figure 1 Flow chart of the selection of veterans with
episodes of mild traumatic brain injury (mTBI) associated with
loss of consciousness (LOC).
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probably had mTBI without LOC. We excluded eight
veterans who had moderate or penetrating TBI. The size
of the comparison group of combat veterans with mTBI
without LOC reﬂects the small fraction of veterans who
did not have LOC among the 155 veterans examined by
RLR. The 155 veterans examined by RLR had under-
gone two prior screening evaluations that indicated
the veterans had mTBI with persisting residual symp-
toms such as headache. Seventy-nine/126 veterans
(62.7%) who had combat mTBI with LOC and 12/21
(57.1%) who did not have LOC were National Guard or
Reservists.
Veterans with civilian mTBI
We evaluated 36 veterans for TBI with LOC in a civilian
environment. These veterans did not report prior
episodes of TBI, including during military service. They
were evaluated within 3 months of the mTBI. Thus, each
veteran in this group experienced the ﬁrst episode of
mTBI as a civilian. We excluded 12 veterans because they
did not have TBIdsix, had moderate TBIdthree, or
because they were more than 65 years olddthree. The
age exclusion was because we did not expect to have
combat veterans >65 years old. Etiologies of mTBI were
motor vehicle accident (MVA)deight, work-related
TBIdseven (ﬁve falls), sportingdthree, non-work falld
two, and assaultdone.
Neurological examination
Neurological examination was previously described and
included 50 scored elements (online appendix 1).
13
This examination included a screening test of cognitive
function; cranial nerve testing; motor function testing,
including assessment of tone, muscle bulk, strength
and symmetry of movements; sensory function including
sensation in the extremities and face and extinction
of sensation with simultaneous stimulations; extremity
coordination and precision of movement; stability
of standing and gait. We included a 12-item quantitati-
ve olfactory test (Brief Smell Identiﬁcation Test;
Sensonics, Haddon Heights, New Jersey, USA, http://
www.sensonics.com).
14 Each scent was evoked in
a standardised manner, and the veteran identiﬁed the
scent from a list of possibilities. The olfactory test had
age-adjusted normal values.
15 Normal olfaction were
scores $7/12 for <55 years old and $5/12 for $55 years
old. We elicited no histories of impaired olfaction
before OIF/OEF deployments. We chose the Montreal
Cognitive Assessment (MOCA) Test to measure cognitive
function because it is widely used within the Veterans
Health Administration, it does not have a licensing
fee and it has been used for repeated measures.
16
Performance on the MOCA is inﬂuenced by age and
other demographic factors.
17 The median ages of
the subjects in the three study groups indicate that the
expected normal range of scores would be 26e30.
17
RLR administered the MOCA after obtaining the TBI
history.
Every combat veteran was assessed for PTSD
Every combat veteran was assessed for PTSD using the
Primary Care PTSD Screen (PC-PTSD).
18 The initial
screen had four questions about PTSD symptoms. If
a veteran acknowledged any three items, the screen was
considered positive. Veterans who screened positive were
assessed using a 17-item National Center for PTSD
checklist for symptoms of military PTSD (PCL-M),
19 and
the veterans were referred for further evaluation by
a mental health professional qualiﬁed to diagnose PTSD.
The mental health professional would often employ
other PTSD evaluation instruments including the
Mississippi Scale for Combat Related Posttraumatic
Stress Disorder.
20 Each veteran had an interview to assess
for the presence and severity of PTSD. Mental health
professionals chose an interview instrument based upon
their familiarity with the instrument and suitability to
assessment of PTSD associated with military service. The
most common interview instrument used was the Clini-
cian Administered PTSD Scale.
21 Mental health profes-
sionals initiated treatment plans based upon assessment
of the strengths of each veteran and the likeliness that
a veteran would beneﬁt from different treatment
options.
22
PTSD diagnosis satisﬁed the American Psychiatric
Association’s Diagnostic and Statistical Manual of Mental
Disorders, 4th edition, criteria of at least one intrusion
item (eg, PCL-M questions 1e5), three avoidance (eg,
PCL-M questions 6e12) and two hyper-arousal symptoms
(eg, PCL-M questions 13e17).
19 Symptoms rated as
‘moderately severe’ or greater (responses three through
ﬁve) were counted as present. In addition, the individual
had to have substantial distress indicated by a PCL-M
score of >50.
19
Statistical methods
Independent variables were (1) mTBI episodes with
LOC, (2) smoking history and (3) OIF/OEF deployment
duration. Dependent variables were (1) NDs, (2) olfac-
tory score, (3) presence of PTSD, (4) PCL-M score and
(5) MOCA score. The primary outcome measures were
two categorical variables: the presence of NDs and
presence of PTSD. The secondary outcome measures
were olfaction scores, PCL-M scores and MOCA scores.
We studied the relationship between the prevalence of
ND/PTSD and the number of LOC episodes. We also
studied the relationship between the number of LOC
episodes and MOCA scores, PCL-M scores or olfactory
test results.
We compared the MOCA scores using the two-sided
t test and olfaction scores using both the two-sided t test
and the nonparametric Wilcoxon rank-sum test.
23
Outcome frequencies were analysed by Pearson’s c
2 test
procedure or Fisher’s exact test. In table 2, we evaluated
the correlations between episodes of LOC and the
presence of an ND or PTSD using generalised Spear-
man’s rank correlation coefﬁcients.
24 The correlations
of MOCA, PCL-M and olfactory test scores and the
numbers of episodes of LOC were evaluated using
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23 Correlations of
MOCA scores with PCL-M and olfaction scores were
obtained using both Kendall’s rank correlation analysis
and Pearson’s productemoment correlation coefﬁ-
cient.
23 The Bonferroni method was used to correct
for multiple comparisons.
25 The Bonferroni p value
(pBonferroni) adjusts the raw p value (praw) for the
number of times that a hypothesis is tested (number of
comparisons ¼ m), pBonferroni ¼ m$praw. If the adjusted p
value exceeds 1, it is set to 1. The Bonferroni test is
conservative but always controls the familywise error rate.
The probability values shown in tables 1 and 2 were
corrected using the Bonferroni method. Values are
presented as means 6 SE of the mean.
RESULTS
The veteran groups had similar demographic features.
The mean ages were combat veterans with LOC
(n¼126)d29.262.6 years (range 20e62 years), combat
veterans without LOC (n¼21)d30.061.6 years (range
21e48 years), and veterans with civilian mTBI (n¼21)d
35.162.2 years (range 21e53 years). The combat
veterans older than 40 years were National Guard or
Reservists. The percentages of women/high school
graduates/college graduates were combat veterans
with LOCd7.9/100/8.7, combat veterans without
LOCd9.5/100/5, and veterans with civilian mTBId9.5/
100/9.5. The two groups of combat veterans had
similar mean numbers of deployments/total deployment
lengths: combat veterans with LOCd1.4360.06 deploy-
ments (range 1e4 deployments)/81.463.2 weeks (range
40e208 weeks), and combat veterans without LOCd
1.7660.25 deployments (range 1e4 deployments)/
90.8612.0 weeks (range 40e208 weeks).
Veterans with combat-acquired mTBI with LOC had
low MOCA scores and high frequencies of an ND and
the presence of PTSD (table 1). ND were reduced
olfactiond65, impaired balanced14, abnormal eye
movementsd13, motor asymmetrydtwo, and sensory
changedtwo. Twenty-nine veterans had more than one
ND. Among the 65 veterans with NDs, 36 (55%) had
Table 1 Frequencies of abnormalities on neurological testing, PTSD and MOCA scores for combat veterans with combat
mTBI, combat veterans who did not have LOC and veterans who sustained mTBI in a civilian setting
Patient group
Deﬁcit on
neurological
examination
Deﬁcits on neurological
examination other than
olfaction PTSD MOCA scores
Combat veterans with
mTBI (n¼126)
65 (52%) 29 (23%) 83 (66%) 25.160.18
Combat veterans without
LOC (n¼21)*
0 (0%), p<0.001 0 (0%), p<0.001 2 (9.5%), p<0.001 28.860.29, p<0.001
Combat veterans with
deﬁnite mTBI without
LOC (n¼16)*
0 (0%), p<0.001 0 (0%), p<0.001 1 (6.25%), p<0.001 28.960.32, p<0.001
Veterans with civilian
mTBI (n¼21)
2 (9.5%), p<0.001 1 (4.8%), p<0.001 1 (4.8%), p<0.001 28.460.23, p<0.001
Probabilities are for comparisons to combat veterans who sustained mTBI with LOC in combat.
*Sixteen had deﬁnite mTBI without LOC and ﬁve had probable mTBI without LOC.
LOC, loss of consciousness; MOCA, Montreal Cognitive Assessment; mTBI, mild traumatic brain injury; PTSD, post-traumatic stress disorder.
Table 2 Correlations between the number of episodes of LOC and the presence of PTSD, presence of an ND, MOCA scores,
PCL-M scores or olfactory test results for combat veterans
Correlation of episodes of mTBI with outcomes and correlation
of PCL-M and olfaction tests scores with MOCA scores
mTBI associated with combat
Correlation coefﬁcient p Value
LOC vs ND (including olfaction) 0.314 <0.01
LOC vs ND (excluding olfaction) 0.254 <0.01
LOC vs PTSD 0.405 <0.01
LOC vs MOCA score  0.226 <0.01
LOC vs PCL-M score 0.577 <0.01
LOC vs olfaction score  0.665 <0.01
MOCA score vs PCL-M score  0.620 ( 0.765) <0.001 for both
MOCA score vs olfaction score 0.00497 (0.0926) NS for both
PCL-M vs olfaction  0.194 NS
Kendall’s rank correlation analysis coefﬁcients are shown in the table with Pearson’s productemoment correlation coefﬁcients shown in
parentheses.
LOC, loss of consciousness; MOCA, Montreal Cognitive Assessment; mTBI, mild traumatic brain injury; ND, neurological deﬁcit; PTSD, post-
traumatic stress disorder.
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using the Romberg test.
26 The most frequently recog-
nised abnormal eye movement was saccadic dysmetria
(12 individuals), with one individual having asymmetric
horizontal saccade velocity.
27 Motor asymmetry was
detected with arm-rolling and upper extremity drift that
were both present in two subjects.
28 The two veterans
with sensory changes had extinction on simultaneous
stimulation.
Half of the 126 veterans with combat mTBI had PTSD
and an ND, 21 (17%) had PTSD without an ND, ﬁve
(4%) had an ND without PTSD and 37 (29%) did not
have PTSD or an ND. Among the 63 veterans with PTSD
and an ND, mean MOCA scores were 24.060.26 and
they were deployed 41.362.03 weeks, whereas veterans
who did not have PTSD or an ND had higher MOCA
scores (26.560.23, p<0.001) but similar durations of
deployment, 38.863.09 weeks.
In contrast, 21 combat veterans who did not have LOC
episodes had no NDs, a lower frequency of PTSD and
higher MOCA scores (table 1). Their olfaction scores
were higher than the 61 veterans who sustained mTBI
with LOC without an ND, 11.160.17 vs 10.660.34
(p<0.01). The comparison group of 16 veterans who
had deﬁnite episodes of mTBI without LOC also had
a lower frequency of PTSD and higher MOCA scores
(table 1). The olfaction scores of the group of 16
veterans were also higher than the scores of the veterans
who had mTBI with LOC without an ND, 11.2560.11
(p<0.01).
Because the most frequent ND was impaired olfaction,
we considered other causes of olfactory impairment:
smoking,
29 upper respiratory infection
30 and nasal sinus
disease.
30 Smoking frequencies among combat veterans
with or without NDs were similar (38.4% vs 39.34%,
p-NS). Four veterans had upper respiratory congestion
at the time of olfactory testing (1) or within the prior
month (3). When retested 6e8 weeks later, the olfactory
score for three veterans did not change. The score of the
veteran with a symptomatic upper respiratory infection
when initially tested improved to normal. The normal
score was used for analysis. The frequencies of histories
of nasal sinus disease were similar for veterans who had
impaired olfaction (7.7%) versus those with normal
olfaction scores (8.2%). Head imaging studies were not
routinely done; however, 34 veterans with an ND
(52.3%) and 31 veterans without an ND (50.8%) had an
MRI or CTscan that visualised the sinuses. Four imaging
studies for veterans with an ND (12%) and four for
veterans without an ND (13%) revealed unilateral sinus
disease. No individual had bilateral sinus ﬁndings.
Veterans with combat mTBI experienced 380 episodes
of LOC, mean of 3.0260.20 episodes of LOC per veteran
(range of 1e8 episodes of LOC for a veteran, online
appendix 2 shows the numbers of veterans with speciﬁc
numbers of episodes of LOC). Most episodes of LOC
were associated with an explosion. Explosions occurred
with 304 episodes of LOC (80%). Each veteran with
LOC had at least one episode of LOC associated with
an explosion. Factors contributing to combat mTBI
were improvised explosive deviced261, MVAd197,
rocket-propelled grenaded52, artillery/mortard32,
bombd20, and blunt trauma not associated with
explosion or MVAd10. Combat mTBI could have several
contributing factors. Explosions were often associated
with an MVA. Five veterans reported one LOC in a non-
combat setting caused by fall, ﬁght, MVA, sports injury
and striking a doorframe. Veterans also experienced
episodes of AOC without LOC (only AOC).
The presence of an ND (including or excluding
veterans whose only ND was impaired olfaction), the
presence of PTSD, MOCA, PCL-M and olfaction scores
were related to the number of episodes of LOC (table 2,
ﬁgure 2). The mean MOCA score for one episode of
combat-acquired LOC was 26.160.34 (n¼34) and
25.360.36 for two episodes of LOC (p<0.05). Veterans
with ﬁve or more episodes of LOC had mean MOCA
scores of 24.260.41 (p<0.05 compared with two
episodes of LOC). In contrast, the strengths of associa-
tions were weakened by considering mTBI episodes with
only AOC. Associations of episodes of LOC + only AOC
episodes were NDd0.131, PTSDd0.262, and
MOCAd0.085 (all p<0.001). There were no associations
of NDs, PTSD or MOCA scores with episodes of only
AOC.
For veterans with PTSD, MOCA scores correlated
inversely with PTSD severity measured with PCL-M scores
(table 2, ﬁgure 3A). However, there was no correlation
between MOCA and olfaction scores for veterans with an
ND (table 2, ﬁgure 3B) or veterans with normal olfaction
(data not shown). For veterans with PTSD and impaired
olfaction, PCL-M scores were not correlated with
olfaction scores (table 2, ﬁgure 4).
We compared OIF/OEF veterans with a group of 21
veterans who sustained mTBI with LOC in a civilian
setting to evaluate the contribution of a combat setting
(table 1). Neither group reported episodes of TBI before
military service. Veterans with civilian mTBI reported
no TBI during military service. All veterans with civilian
mTBI had one episode of LOC. Intervals from the
last TBI differed. Veterans with combat TBI were
seen 122.664.4 weeks after the last TBI (range
40e212 weeks). This time reﬂected the time OIF/OEF
veterans spent in the military before they were
discharged and the time it took for the OIF/OEF
veterans to obtain care through the CVAMC. We evalu-
ated veterans with civilian TBI 8.3860.53 weeks (range
4e12 weeks, p<0.001) after mTBI. Veterans with civilian
mTBI had fewer NDs, lower frequency of PTSD and
higher MOCA scores compared with those with combat
mTBI (table 1). However, when veterans with civilian
mTBI were compared with the 34 veterans who had one
episode of combat mTBI, the two groups had similar
frequencies of NDs of 4/34 (11.8%) for combat mTBI
and 2/21 (9.5%, p-NS) for civilian mTBI. The two
veterans with civilian mTBI and initial NDs did not have
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between TBI and evaluation comparable to the interval
for combat mTBI. Due to the small sizes of the groups of
veterans with mTBI and one episode of LOC, the ND
prevalence values remained not signiﬁcantly different.
MOCA scores for veterans with civilian mTBI (table 1)
were higher than for veterans with one episode of
combat-associated LOC, 26.160.34, p<0.001. PTSD was
more common for combat veterans with one episode of
LOC (32.4% vs 4.8%, p¼0.0194).
DISCUSSION
The data provided clear answers to the research ques-
tions: (1) the most frequent ND recognised was
impaired olfaction that was discovered using quantitative
olfactory testing and (2) there were deﬁnite associations
between the number of episodes of mTBI with LOC and
presence of NDs (both olfaction and NDs other than
impaired olfaction) as well as an increase in the likeli-
hood than a veteran would have PTSD with increased
number of episodes of mTBI with LOC (ﬁgure 2). In
Figure 2 Effect of number of
episodes of loss of consciousness
(LOC) on outcomes for veterans
with combat-acquired mild
traumatic brain injury: (A) olfaction
scores, (B) post-traumatic stress
disorder (PTSD) severity as
measured by the PCL-M score,
(C) score on the Montreal
Cognitive Assessment (MOCA)
Test and (D) the prevalence of
abnormalities on neurological
examination (unﬁlled circles) or
PTSD (ﬁlled squares). The
correlation coefﬁcients for the
association between the number
of episodes of LOC and the
olfaction scores, PCL-M scores
and MOCA score are shown in
table 2. The straight lines in A, B
and C correspond to Kendall’s
rank correlation analysis
coefﬁcients in table 2.
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and reduction in MOCA scores increased with the
number of episodes of LOC (ﬁgure 2). The most
frequently recognised ND was impaired olfaction
followed by impaired balance and abnormal saccades.
Testing for olfaction using a ‘scratch and sniff’ instru-
ment is easy to do in a clinic setting, has been validated
for different subject groups and is amenable to a variety
of settings including a combat environment.
14 15 We
advocate incorporating olfaction testing into neurolog-
ical examinations for TBI. Among the items in the 50
element neurological examination, the other elements,
aside from olfaction, that indicated neurological
dysfunction were the Romberg test, observation of
saccades, asymmetric arm rolling/arm drift and consis-
tent unilateral sensory extinction on simultaneous light
touch stimulation of both upper extremities. About
40% of civilians with TBI have impaired balance
31 or
impaired eye movements.
32 However, specialised testing
environments are needed to detect the subtle changes in
balance or eye movements produced by mTBI. These
assessments are not done in a clinic setting. Olfactory
testing is the most sensitive indicator of persisting injury
following TBI that can be done in a clinic setting and is
a good test for remote TBI because olfaction usually
does not recover after TBI.
33
We found the strongest associations between outcomes
(NDs, PTSD and MOCA scores) and episodes of LOC.
Veterans who experienced episodes of LOC had MOCA
scores that were mildly reduced compared with those
who did not experience episodes of LOC. The absolute
differences in MOCA scores between different groupings
of the veterans in this study were small, even though the
differences may have been statistically signiﬁcant. The
high frequency of episodes of LOC associated with
a blast prevented us from being able to discern differ-
ences between episodes of LOC associated with explo-
sions and episodes of LOC not associated with
explosions. All the veterans who had an episode of LOC
had at least one episode of LOC associated with an
explosion. When episodes of AOC as well as LOC were
considered, the correlations were weaker and there were
no correlations for episodes of AOC alone. We could not
distinguish prevalence differences for NDs following
civilian versus combat mTBI, but the numbers of
veterans with one episode of LOC were small.
Several biases may have inﬂuenced this study. Episodes
of TBI were historical. In some instances, veterans may
have underestimated the duration of LOC so that some
episodes of mTBI may have really been episodes of
moderate TBI. Neurological examinations were not
blinded. However, the olfaction test and the MOCA are
objective tests that reduce the likelihood that RLR
inﬂuenced veterans’ performance. Due to the nature of
the armed conﬂicts in the Middle East with repeated
deployments for US combat troops and because episodes
of mTBI were not likely to remove one from combat
responsibilities, there could be a long time between the
last episode of mTBI and VA assessment. This was not
a random sample of veterans who sustained mTBI in
OIF/OEF. Veterans who sustained mTBI without
persisting problems would be less likely to seek treat-
ment from the CVAMC, and veterans who had
Figure 3 Association of the
scores on the Montreal Cognitive
Assessment (MOCA) Test with (A)
post-traumatic stress disorder
(PTSD) severity as measured by
the PCL-M score for veterans with
PTSD or (B) olfaction scores for
veterans with neurological deﬁcits
including impaired olfaction. The
correlation coefﬁcients for the
association between the MOCA
scores and the PCL-M scores are
shown in table 2. There was no
association between MOCA
scores and olfaction scores. The
straight line in A corresponds to
Kendall’s rank correlation analysis
coefﬁcient in table 2.
Figure 4 Association of the PCL-M and olfaction test scores
for veterans with both NDs and post-traumatic stress disorder.
The correlation coefﬁcient for the association between the
PCL-M scores and olfaction scores is shown in table 2. There
was no signiﬁcant association between PCL-M scores and
olfaction scores.
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might misremember that an episode of trauma included
mTBI when there was no TBI. The associations of NDs
with episodes of mTBI suggest that the recalled episodes
of mTBI were associated with cerebral injury. There were
relatively few subjects in the comparison group of
combat veterans who had mTBI without LOC. The size
of this group was not representative of the expected
fraction of combatants with mTBI without LOC. In
two studies of military personnel who returned from
deployment in Iraq or Afghanistan, between 26% and
32% of those who reported an episode of TBI reported
having LOC.
4 34 However, the comparison groups were
only used for the data shown in table 1. The data
presented in the other table and ﬁgures do not involve
the comparison groups. The presence of combat
veterans up to 62 years of age may be due to two factors:
(1) the delay between end of military service and
enrolment for VHA care and (2) that 63% of those with
LOC were National Guard or Reservists.
The MOCA is a cognitive screening test. Performance
on the MOCA decreases with age and extent of educa-
tion. The subjects in this study all had at least 12 years of
formal education and were <65 years of age so that
age would not be expected to have had a prominent
effect on their MOCA performance.
17 As a cognitive
function test, the MOCA is not as sensitive as detailed
intelligence testing, but detailed intelligence testing
would have taken longer times to administer. The MOCA
has been used as a cognitive screening test for neuro-
logical disorders such as Parkinson’s disease and stroke,
and the MOCA is more sensitive than some other
cognitive screening tests such as the Mini-Mental State
Examination.
35 36
Veterans with combat mTBI frequently complain of
impaired cognition.
8 Did PTSD or NDs have the stron-
gest inﬂuence on veterans’ performance? PCL-M scores
correlated with cognitive performance on the MOCA.
Our data indicating that PTSD severity inﬂuenced
cognitive performance is consistent with prior sugges-
tions that PTSD inﬂuenced post-deployment symptoms
including poor cognition.
4 The lack of association
between MOCA and olfaction scores may indicate that
the MOCA test is not sensitive to damage to orbital
frontal cortex associated with impaired olfaction.
37 We
found that deployment duration and the number of
deployments were similar for veterans who did or did
not suffer NDs and PTSD, which argues against NDs or
PTSD resulting from factors that may be related to
deployment durations such as exposure to a possible
Middle East pathogen.
Was impaired olfaction caused by mTBI or other
factors? Olfactory function can be impaired by smoking,
sinus disease and inhalation of irritants.
29 30 38 We found
no increase in smoking prevalence among veterans with
impaired olfaction or differences in the history or pres-
ence of sinus disease. Exposure to pollutants and
smoke, which may be present in a combat environment,
produces w12% decrease in olfaction test scores,
38
which would not explain our ﬁndings. PTSD does not
compromise olfaction,
39 and we found that olfactory
impairment did not correlate with PTSD severity.
Therefore, we believe that reduced olfaction scores were
likely due to repeated episodes of mTBI.
Quantitative tests of olfaction have not been used
previously in studies of combat TBI. In one civilian study
of mTBI, 22% of subjects had hyposmia and 4% had
anosmia after one mTBI.
40 We found that 12% of
veterans with combat mTBI and one episode of LOC had
hyposmia. Civilian subjects may have had a higher
prevalence of impaired olfaction because they were
evaluated sooner. Injured olfactory nerve ﬁbres can
recover over time leading to recovery of olfaction during
the ﬁrst year after TBI.
41 Consequently, the veterans that
we evaluated who had impaired olfaction, likely had
permanent olfaction impairments. These olfaction
impairments were usually not recognised by the
veterans.
We believe that the olfaction deﬁcits did not result in
any functional limitations. The importance of the
olfaction deﬁcits was that they were markers of cerebral
injury, speciﬁcally frontal lobe injury. The following text
describes the relationships between TBI and impaired
olfaction and how cerebral damage including injury to
the ventromedial frontal lobes can enhance the likeli-
hood that a psychologically traumatic event leads to the
genesis of PTSD.
TBI usually impairs olfaction by shearing the olfactory
nerves traversing the cribiform plate, bruising the
orbital frontal cortex or both.
37 A study of US military
personnel who sustained an episode of combat TBI,
predominantly mTBI, in OIF/OEF found that 29% of
subjects had white matter lesions in two or more areas of
interest.
42 The areas of injury were orbital frontal cortex,
cingulum and middle cerebellar peduncles. The ﬁnding
of orbital frontal cortex injury associated with combat
mTBI provides a structural cerebral correlation for our
observation of impaired olfaction.
Civilian TBI studies indicate that neurological
dysfunction correlates with the number of TBI events.
43 44
Recovery from mTBI is slower following repeated
mTBIs.
45 Repeated sports concussions compromise
cerebral electrical activity and metabolism.
46 47 Dementia
and cerebral degeneration may be delayed consequences
of repeated concussions.
48 49 Our observation that ND
prevalence increased with combat mTBI episodes is
consistent with observations from civilian concussions.
The increase in PTSD prevalence that we observed
with LOC episodes may be due to several factors. The
events causing LOC may have produced sufﬁcient
psychological trauma to induce PTSD. The presence of
mTBI may have increased the likelihood that a psycho-
logically traumatic event resulted in PTSD.
50 A study of
the development of anxiety disorders in children
following TBI found that 8.5% of children developed
anxiety disorders, usually PTSD, within 6 months of the
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51 Children with mTBI had the greatest likelihood of
developing PTSD. An Australian study of civilian trauma
reported that the prevalence of PTSD following mTBI
was 6%, which was about 1.9-fold higher than following
trauma without TBI.
52 PTSD and mTBI are associated in
combat personnel. About 40% of military personnel and
veterans with combat-acquired mTBI have PTSD.
48
Among soldiers recently deployed in Iraq who experi-
enced an episode of LOC due to mTBI, 44% had PTSD
compared with 16% for soldiers with other injuries and
9% for uninjured soldiers.
4
‘Data suggest that PTSD is associated with over acti-
vation of the amygdala due to a lack of inhibitory control
by ventromedial prefrontal cortex, as well as deﬁcient
hippocampal function.’
53 The areas of brain injury
identiﬁed by functional imaging in PTSD including
ventromedial frontal lobes and medial temporal
lobes
54 55 are included within the areas damaged in
mTBI.
42 56e58
In this study, impaired olfaction was the most
frequently recognised ND. To the extent that impaired
olfaction is a marker for injury to orbital frontal cortex,
impaired olfaction may be a ﬂag for a cerebral injury
that can facilitate the development of PTSD. The asso-
ciation of impaired olfaction with the presence of PTSD
and PTSD severity is consistent with impaired olfaction
being a marker for damage to orbital frontal cortex with
reduced inhibition of the amygdala enabling anxiety and
exaggerated fear responses.
53
Pre-existing subtle (‘soft’) ND may increase the risk of
developing PTSD.
59 The 45 neurological soft signs
assessed in Vietnam veterans were similar to the 50 items
in the neurological examinations performed in this
study but did not include olfaction testing. In studies of
monozygotic twins where one twin was in combat and
the other not, among twins pairs where one had combat-
associated PTSD, both twins had a higher prevalence of
neurological soft signs
59 or grey matter abnormalities in
the right hippocampus, pregenual anterior cingulate
cortex and left and right insular cortex
60 than the twins
where the combat-exposed twin did not have PTSD. The
twin studies suggested that subtle genetically based NDs
can potentiate the genesis of PTSD. This is, however,
distinct from the ﬁndings of the Vietnam Head Injury
Program (VHIP)
53 where veterans with combat pene-
trating TBIs were classiﬁed based on lesion location. The
prevalence of PTSD was compared across groups.
Patients with amygdala or ventromedial frontal injuries
had reduced prevalence of PTSD. The apparent
contradiction between the twins and VHIP studies may
be due in part to differences in the severity of the
injuries. Subjects in the twin studies had subtle perfor-
mance and imaging deﬁcits compared with the pene-
trating injuries in the VHIP study. Mild injury may
potentiate PTSD genesis by slightly disrupting normal
interactions among the amygdala, ventromedial frontal
cortex and hippocampus, whereas more severe injury
may prevent “the ‘super-normal’ levels of fear/anxiety
that deﬁne PTSD.”
53 In childhood TBI, development of
PTSD and other anxiety disorders correlated with MRI-
identiﬁed damage to the superior frontal gyrus, anterior
frontal white matter and orbital frontal cortex.
51 Overall,
the risk of an individual with combat TBI developing
PTSD may be higher for mTBI compared with severe
TBI.
61 Children with mTBI had a greater likelihood of
developing PTSD than children who had severe TBI.
51
In addition, penetrating injuries may have been more
focal and less likely to have the more diffuse axonal
effects of closed head injury. We found that PTSD
severity was not associated with the severity of olfaction
impairment. Perhaps the presence of injury to orbital
cortex predisposes to PTSD, but severity of cortex injury
is not the primary factor controlling PTSD severity. Our
observation that the severity of olfaction impairment was
related to the number of LOC events suggests that
impaired olfaction was related to combat mTBI rather
than being pre-existing deﬁcits.
Several factors can enhance or reduce the likelihood
that a psychologically traumatic event results in devel-
opment of anxiety disorders including PTSD. For
example, psychological resiliency, a supportive social
environment and higher levels of intelligence and
education may reduce the likelihood of an individual
developing PTSD.
22 62 This study suggests that mTBI in
a combat setting may enhance the likelihood of an
individual developing PTSD. Additional studies are
needed to support or refute the suggestion from this
study that mTBI increases the likelihood that combat
trauma leads to PTSD.
There is a tendency to attribute physical symptoms
after deployment to PTSD rather than to mTBI.
4 Future
studies of combat TBI will determine the extent to which
our ﬁndings of increased prevalence of PTSD and NDs
with episodes of LOC generalise to other populations of
military personnel and in other settings. Given the
results detailed in this study suggesting a relationship
between mTBI and PTSD, perhaps the focus of future
studies should shift from ascribing cognitive deﬁcits and
physical symptoms to one diagnosis versus another to
understanding the impact of repeated combat mTBI on
development of PTSD.
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